BIO Policy Pulse: BIO Board Member Testifies at IP Hearing

BIO Board member Eddie J. Sullivan testifies at the House Ways and Means Trade Subcommittee about the impact an expanded IP waiver would have on innovative biotechs like SAb Biotherapeutics.
Bio.News: https://bio.news/international/wto-ip-waiver-biotech-innovation-sab-biotherapeutics-capitol-hill/
(Feb. 7, 2024)

source